DCHA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DCHA, covering 2018-03-05 to 2018-03-05. Get the full timeline:
Most recent: Clinical Trial Update: DCHA as Postremission Therapy for AML With t(8;21) [Phase 1, Phase 2]